Who
Masoud Toloue
President & CEO
Company insider
Files Form 4 as: President & CEO, Quanterix.
In numbers
- Trades disclosed
- 79
- Buys
- 3
- Sells
- 3
- Bought
- $1.6M
- Sold
- $99K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jun 2021
- Last trade
- 15 Jan 2026
- Last filed
- 20 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jan 2026filed 20 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $14K1,817 at $7.95 | filing |
| 15 Jan 2026filed 20 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $14K1,817 at $7.95 | filing |
| 31 Dec 2025filed 5 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,641258 at $6.36 | filing |
| 31 Dec 2025filed 5 Jan 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,641258 at $6.36 | filing |
| 15 Dec 2025filed 18 Dec 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $9,2031,242 at $7.41 | filing |
| 30 Nov 2025filed 3 Dec 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,844254 at $7.26 | filing |
| 15 Nov 2025filed 24 Nov 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $7,1291,242 at $5.74 | filing |
| 31 Oct 2025filed 5 Nov 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,356254 at $5.34 | filing |
| 15 Oct 2025filed 17 Oct 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $7,1791,242 at $5.78 | filing |
| 30 Sep 2025filed 2 Oct 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,379254 at $5.43 | filing |
| 15 Sep 2025filed 17 Sep 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $6,1731,242 at $4.97 | filing |
| 31 Aug 2025filed 3 Sep 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,156254 at $4.55 | filing |
| 15 Aug 2025filed 19 Aug 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $5,6761,242 at $4.57 | filing |
| 31 Jul 2025filed 4 Aug 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,509254 at $5.94 | filing |
| 15 Jul 2025filed 17 Jul 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $6,8191,242 at $5.49 | filing |
| 30 Jun 2025filed 2 Jul 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,689254 at $6.65 | filing |
| 15 Jun 2025filed 17 Jun 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $7,5271,242 at $6.06 | filing |
| 9 Jun 2025filed 10 Jun 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Bought | $249K45,900 at $5.42 | filing |
| 31 May 2025filed 3 Jun 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $1,321254 at $5.20 | filing |
| 15 May 2025filed 19 May 2025 | QTRX QuanterixLife-science tools | SEC FORM 4 Code F | $5,5891,242 at $4.50 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisQTRX · tickerreport.com · 15 Oct 2026ALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker ResearchQTRX · prnewswire.com · 8 Oct 2026
0 headlines in the last 90 days name Masoud Toloue; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.